4. Ignore the twin gods of biotech -- risk and failure -- at your peril. On Sept. 21, Peregrine was up 829% for the third quarter. Enough said.
5. Why the hell was Savient up 363% in the third quarter? No one has a clue.
-- Reported by Adam Feuerstein in Boston. Follow @AdamFeuerstein